Smiths Medical has obtained the US Food and Drug Administration's (FDA) 510(k) clearance for its new CorrectInject safety system, designed to minimize the risk of tubing misconnections that occur during spinal and epidural anaesthesia administration.
The CorrectInject, a neuraxial medication delivery system, features safety connectors which deliver spinal and epidural medications to the neuraxial region.
The company said connectors of Portex CorrectInject safety system are differentiated from intravenous Luer connectors or intravenous infusion spikes with its tapered and threaded ends.
The new system’s yellow components visually signify a neuraxial delivery route and helps clinicians to check whether the medication to be delivered is appropriate for the treatment location.
Smiths Medical president Srini Seshadri said the company is providing a new solution that will help clinicians to reduce medication delivery errors during spinal and epidural anaesthesia administration.
"As a global leader of safety medical devices, it is our obligation to develop innovative medical products that not only help protect patients when they are most vulnerable but help to raise clinical standards of care," Seshadri added.